Showing results (2721-2730 of 6,780) with videos related to

Sort By:
Pageof 678
Clinical Therapeutics|March 14, 2018
An Overview of Immune Checkpoint Inhibitors in Gynecologic CancersTara Castellano, Kathleen N Moore, Laura L Holman
Clinical Therapeutics|November 27, 2018
Effects of the Intravenous Calcimimetic Etelcalcetide on Bone Turnover and Serum Fibroblast Growth Factor 23: Post Hoc Analysis of an Open-label StudyTakashi Shigematsu, Masafumi Fukagawa, Keitaro Yokoyama, et al.
Clinical Therapeutics|February 6, 2019
Cyclophosphamide + Thalidomide + Dexamethasone Versus Melphalan + Dexamethasone for the Treatment of Amyloid Light-chain Amyloidosis With Kidney Involvement: A Retrospective Study in Chinese PatientsBaojian Liu, Yan Wang, Ming Bai, et al.
Clinical Therapeutics|March 26, 2018
Benefits and Challenges of Lung Cancer Screening in Older AdultsMeytal S Fabrikant, Juan P Wisnivesky, Thomas Marron, et al.
Clinical Therapeutics|October 9, 2007
A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitisJosefine Gradman, Mark F Caldwell, Ole D Wolthers
Clinical Therapeutics|April 28, 2009
Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety studyPaul Karpecki, Michael Depaolis, Judy A Hunter, et al.
Clinical Therapeutics|April 28, 2009
Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgeryStanislav Oifa, Tatiana Sydoruk, Ian White, et al.
Clinical Therapeutics|April 28, 2009
An open-label, single-dose, parallel-group, dose-increasing study comparing the pharmacokinetics and tolerability of pilsicainide hydrochloride in healthy Korean and Japanese male subjectsBo-Hyung Kim, Jung-Ryul Kim, Kyoung Soo Lim, et al.
Clinical Therapeutics|May 19, 2009
Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: two single-dose, open-label, randomized-sequence, crossover studiesDaphne D Williams, Bin Peng, Christine K Bailey, et al.
Clinical Therapeutics|May 19, 2009
Pharmacokinetic properties and bioequivalence of two formulations of arbidol: an open-label, single-dose, randomized-sequence, two-period crossover study in healthy Chinese male volunteersMing-Yan Liu, Shuang Wang, Wei-Fan Yao, et al.
Pageof 678